Distributional comparison of different AAV vectors after unilateral cochlear administration

World Health Organization. Deafness and Hearing Loss. 2023. https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss.

Andres-Mateos E, Landegger LD, Unzu C, Phillips J, Lin BM, Dewyer NA, et al. Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate. Nat Commun. 2022; https://doi.org/10.1038/s41467-022-28969-3.

Tao Y, Liu X, Yang L, Chu C, Tan F, Yu Z, et al. AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration. Signal Transduct Target Ther. 2022; https://doi.org/10.1038/s41392-022-00938-8.

Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022; https://doi.org/10.1038/s43586-022-00104-y.

Rubanyi GM. The future of human gene therapy. Mol Aspects Med. 2001;22:113–42.

Article  CAS  PubMed  Google Scholar 

Botto C, Dalkara D, El-Amraoui A. Progress in gene editing tools and their potential for correcting mutations underlying hearing and vision loss. Front Genome Ed. 2021; https://doi.org/10.3389/fgeed.2021.737632.

Snow JB Jr, Wackym PA. Ballenger’s otorhinolaryngology head and neck surgery 17th. Connecticut: People’s Medical Publishing House; 2009.

Google Scholar 

Peters CW, Maguire CA, Hanlon KS. Delivering AAV to the central nervous and sensory systems. Trends Pharmacol Sci. 2021;42:461–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shu Y, Tao Y, Wang Z, Tang Y, Li H, Dai P, et al. Identification of adeno-associated viral vectors that target neonatal and adult Mammalian inner ear cell subtypes. Hum Gene Ther. 2016;27:687–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Isgrig K, McDougald DS, Zhu J, Wang HJ, Bennett J, Chien WW. AAV2.7m8 is a powerful viral vector for inner ear gene therapy. Nat Commun. 2019; https://doi.org/10.1038/s41467-018-08243-1.

Tan F, Chu C, Qi J, Li W, You D, Li K, et al. AAV-ie enables safe and efficient gene transfer to inner ear cells. Nat Commun. 2019; https://doi.org/10.1038/s41467-019-11687-8.

Omichi R, Yoshimura H, Shibata SB, Vandenberghe LH, Smith RJH. Hair cell transduction efficiency of single- and dual-AAV serotypes in adult murine Cochleae. Mol Ther Methods Clin Dev. 2020;17:1167–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landegger LD, Pan B, Askew C, Wassmer SJ, Gluck SD, Galvin A, et al. A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear. Nat Biotechnol. 2017; https://doi.org/10.1038/nbt.3781.

Akil O, Dyka F, Calvet C, Emptoz A, Lahlou G, Nouaille S, et al. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model. Proc Natl Acad Sci USA. 2019;116:4496–501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nist-Lund CA, Pan B, Patterson A, Asai Y, Chen T, Zhou W, et al. Improved TMC1 gene therapy restores hearing and balance in mice with genetic inner ear disorders. Nat Commun. 2019; https://doi.org/10.1038/s41467-018-08264-w.

Pan B, Askew C, Galvin A, Heman-Ackah S, Asai Y, Indzhykulian AA, et al. Gene therapy restores auditory and vestibular function in a mouse model of Usher syndrome Type 1c. Nat Biotechnol. 2017;35:264–72. https://doi.org/10.1038/nbt.3801.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao X, Tao Y, Lamas V, Huang M, Yeh WH, Pan B, et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature. 2018;553:217–21.

Article  CAS  PubMed  Google Scholar 

Taiber S, Cohen R, Yizhar-Barnea O, Sprinzak D, Holt JR, Avraham KB Neonatal AAV gene therapy rescues hearing in a mouse model of SYNE4 deafness. EMBO Mol Med. 2021; https://doi.org/10.15252/emmm.202013259.

Gu X, Wang D, Xu Z, Wang J, Guo L, Chai R, et al. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing. Genome Biol. 2021; https://doi.org/10.1186/s13059-021-02311-4.

Xue Y, Hu X, Wang D, Li D, Li Y, Wang F, et al. Gene editing in a Myo6 semi-dominant mouse model rescues auditory function. Mol Ther. 2022; https://doi.org/10.1016/j.ymthe.2021.06.015.

Zheng Z, Li G, Cui C, Wang F, Wang X, Xu Z, et al. Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing. Signal Transduct Target Ther. 2022; https://doi.org/10.1038/s41392-022-00893-4.

Mathiesen SN, Lock JL, Schoderboeck L, Abraham WC, Hughes SM. CNS transduction benefits of AAV-PHP.eB over AAV9 are dependent on administration route and mouse strain. Mol Ther Methods Clin Dev. 2020;19:447–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu CJ, Lu YC, Tsai YH, Cheng HY, Takeda H, Huang CY, et al. Efficient in utero gene transfer to the Mammalian inner ears by the synthetic adeno-associated viral vector Anc80L65. Mol Ther Methods Clin Dev. 2020;18:493–500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang H, Wang H, Wang S, Hu SW, Lv J, Xun M, et al. Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin. Human Genet. 2022; https://doi.org/10.1007/s00439-022-02504-2.

Wang Y, Menon N, Shen S, Feschenko M, Bergelson S. A qPCR method for AAV genome titer with ddPCR-level of accuracy and precision. Mol Ther Methods Clin Dev. 2020;19:341–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hudry E, Martin C, Gandhi S, György B, Scheffer DI, Mu D, et al. Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Ther. 2016;23:380–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanlon KS, Meltzer JC, Buzhdygan T, Cheng MJ, Sena-Esteves M, Bennett RE, et al. Selection of an efficient AAV vector for robust CNS transgene expression. Mol Ther Methods Clin Dev. 2019;15:320–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Askew C, Rochat C, Pan B, Asai Y, Ahmed H, Child E, et al. Tmc gene therapy restores auditory function in deaf mice. Sci Transl Med. 2015; https://doi.org/10.1126/scitranslmed.aab1996.

Burdett T, Nuseibeh S Changing trends in the development of AAV-based gene therapies: a meta-analysis of past and present therapies. Gene Ther. 2022; https://doi.org/10.1038/s41434-022-00363-0.

Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16:1073–80.

Article  CAS  PubMed  Google Scholar 

Challis RC, Ravindra Kumar S, Chen X, Goertsen D, Coughlin GM, Hori AM, et al. Adeno-associated virus toolkit to target diverse brain cells. Annu Rev Neurosci. 2022;45:447–69.

Article  CAS  PubMed  Google Scholar 

Hudry E, Andres-Mateos E, Lerner EP, Volak A, Cohen O, Hyman BT, et al. Efficient gene transfer to the central nervous system by single-stranded Anc80L65. Mol Ther Methods Clin Dev. 2018;10:197–209.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakrabarty P, Rosario A, Cruz P, Siemienski Z, Ceballos-Diaz C, Crosby K, et al. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS One. 2013; https://doi.org/10.1371/journal.pone.0067680.

Yang B, Li S, Wang H, Guo Y, Gessler DJ, Cao C, et al. Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10. Mol Ther. 2014;22:1299–309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cayé-Thomasen P, Worsøe L, Brandt CT, Miyazaki H, Ostergaard C, Frimodt-Møller N, et al. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis. Laryngoscope. 2009;119:1560–70.

Article  PubMed  Google Scholar 

Goertsen D, Flytzanis NC, Goeden N, Chuapoco MR, Cummins A, Chen Y, et al. AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset. Nat Neurosci. 2022;25:106–15.

Article  CAS  PubMed  Google Scholar 

Liu Y, Okada T, Nomoto T, Ke X, Kume A, Ozawa K, et al. Promoter effects of adeno-associated viral vector for transgene expression in the cochlea in vivo. Exp Mol Med. 2007;39:170–5.

Article  CAS  PubMed  Google Scholar 

Boëda B, Weil D, Petit C. A specific promoter of the sensory cells of the inner ear defined by transgenesis. Hum Mol Genet. 2001;10:1581–9. https://doi.org/10.1093/hmg/10.15.1581.

Article  PubMed  Google Scholar 

Shibata SB, Yoshimura H, Ranum PT, Goodwin AT, Smith RJH Intravenous rAAV2/9 injection for murine cochlear gene delivery. Sci Rep. 2017; https://doi.org/10.1038/s41598-017-09805-x.

Blanc F, Bemelmans AP, Affortit C, Joséphine C, Puel JL, Mondain M, et al. A single cisterna magna injection of AAV leads to binaural transduction in mice. Front Cell Dev Biol. 2022; https://doi.org/10.3389/fcell.2021.783504.

Talaei S, Schnee ME, Aaron KA, Ricci AJ. Dye tracking following posterior semicircular canal or round window membrane injections suggests a role for the Cochlea aqueduct in modulating distribution. Front Cell Neurosci. 2019; https://doi.org/10.3389/fncel.2019.00471.

Bankoti K, Generotti C, Hwa T, Wang L, O’Malley BW Jr, Li D. Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss. Mol Ther Methods Clin Dev. 2021;21:209–36. https://doi.org/10.1016/j.omtm.2021.03.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baldrick P, McIntosh B, Prasad M. Adeno-associated virus (AAV)-based gene therapy products: what are toxicity studies in non-human primates showing us? Regul Toxicol Pharmacol. 2023;138:105332. https://doi.org/10.1016/j.yrtph.2022.105332.

Article  CAS  PubMed  Google Scholar 

György B, Meijer EJ, Ivanchenko MV, Tenneson K, Emond F, Hanlon KS, et al. Gene transfer with AAV9-PHP.B rescues hearing in a mouse model of Usher syndrome 3A and transduces hair cells in a non-human primate. Mol Ther Methods Clin Dev. 2018;13:1–13. https://doi.org/10.1016/j.omtm.2018.11.003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ivanchenko MV, Hanlon KS, Devine MK, Tenneson K, Emond F, Lafond JF, et al. Preclinical testing of AAV9-PHP.B for transgene expression in the non-human primate cochlea. Hear Res. 2020;394:107930. https://doi.org/10.1016/j.heares.2020.107930.

Article  PubMed  PubMed Central  Google Scholar 

Ivanchenko MV, Hanlon KS, Hathaway DM, Klein AJ, Peters CW, Li Y, et al. AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear. Mol Ther Methods Clin Dev. 2021;21:382–98. https://doi.org/10.1016/j.omtm.2021.03.019.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif